Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord
Biomaterials are being developed as therapeutics for spinal cord injury (SCI) that can stabilize and bridge acute lesions and mediate the delivery of transgenes, providing a localized and sustained reservoir of regenerative factors. For clinical use, direct injection of biomaterial scaffolds is pref...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AIP Publishing LLC
2021-03-01
|
Series: | APL Bioengineering |
Online Access: | http://dx.doi.org/10.1063/5.0035291 |